550 Shares in CVS Health Co. (NYSE:CVS) Purchased by Advantage Trust Co

Advantage Trust Co purchased a new stake in CVS Health Co. (NYSE:CVS) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 550 shares of the pharmacy operator’s stock, valued at approximately $43,000.

A number of other institutional investors and hedge funds also recently modified their holdings of CVS. Loudon Investment Management LLC grew its stake in shares of CVS Health by 52.5% during the 4th quarter. Loudon Investment Management LLC now owns 22,521 shares of the pharmacy operator’s stock valued at $1,778,000 after buying an additional 7,753 shares during the period. Oldfield Partners LLP purchased a new stake in CVS Health during the fourth quarter valued at about $355,000. Neumann Capital Management LLC increased its stake in CVS Health by 3.4% during the fourth quarter. Neumann Capital Management LLC now owns 42,716 shares of the pharmacy operator’s stock worth $3,373,000 after acquiring an additional 1,400 shares during the last quarter. Hills Bank & Trust Co lifted its stake in shares of CVS Health by 1.3% in the 4th quarter. Hills Bank & Trust Co now owns 56,566 shares of the pharmacy operator’s stock valued at $4,466,000 after purchasing an additional 749 shares in the last quarter. Finally, US Asset Management LLC acquired a new stake in CVS Health during the 4th quarter worth approximately $378,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling

In other news, Director Edward J. Ludwig purchased 1,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The shares were acquired at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average cost of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE:CVS traded up $0.76 during trading hours on Thursday, hitting $55.67. The stock had a trading volume of 10,298,162 shares, compared to its average volume of 11,874,933. The stock’s fifty day simple moving average is $71.54 and its 200 day simple moving average is $72.96. The firm has a market capitalization of $69.89 billion, a price-to-earnings ratio of 9.79, a PEG ratio of 0.88 and a beta of 0.56. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. CVS Health Co. has a 1-year low of $53.70 and a 1-year high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period last year, the business posted $2.20 earnings per share. Sell-side analysts anticipate that CVS Health Co. will post 7.03 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were given a dividend of $0.665 per share. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 4.78%. CVS Health’s dividend payout ratio (DPR) is 46.75%.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. Bank of America cut their target price on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Piper Sandler upped their target price on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Cantor Fitzgerald lowered CVS Health from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $87.00 to $58.00 in a research report on Wednesday, May 1st. Argus lowered their price objective on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, Leerink Partnrs downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. Nine investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $76.75.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.